1062 related articles for article (PubMed ID: 30917097)
1. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
[TBL] [Abstract][Full Text] [Related]
2. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
Ravi M; Beljorie M; El Masry K
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
[No Abstract] [Full Text] [Related]
4. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
[TBL] [Abstract][Full Text] [Related]
5. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
Stock SJ; Horne M; Bruijn M; White H; Heggie R; Wotherspoon L; Boyd K; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David A; Khalil A; Shennan A; Baaren GV; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol B; Riley RD; Norman J; Norrie J
Health Technol Assess; 2021 Sep; 25(52):1-168. PubMed ID: 34498576
[TBL] [Abstract][Full Text] [Related]
6. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
[TBL] [Abstract][Full Text] [Related]
7. Fetal fibronectin testing for reducing the risk of preterm birth.
Berghella V; Saccone G
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD006843. PubMed ID: 31356681
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of quantitative fFn test in predicting the risk of preterm birth.
Centra M; Coata G; Picchiassi E; Alfonsi L; Meniconi S; Bini V; Di Tommaso MR; Cozzolino M; Facchinetti F; Ferrari F; Gervasi MT; Rusconi S; Todros T; Frisina V; Rizzo N; Bisulli M; Di Renzo GC
J Perinat Med; 2017 Jan; 45(1):91-98. PubMed ID: 27049613
[TBL] [Abstract][Full Text] [Related]
9. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling.
Honest H; Forbes CA; Durée KH; Norman G; Duffy SB; Tsourapas A; Roberts TE; Barton PM; Jowett SM; Hyde CJ; Khan KS
Health Technol Assess; 2009 Sep; 13(43):1-627. PubMed ID: 19796569
[TBL] [Abstract][Full Text] [Related]
10. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
[TBL] [Abstract][Full Text] [Related]
11. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
Frampton GK; Jones J; Rose M; Payne L
Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
[TBL] [Abstract][Full Text] [Related]
12. Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.
Smith GC; Moraitis AA; Wastlund D; Thornton JG; Papageorghiou A; Sanders J; Heazell AE; Robson SC; Sovio U; Brocklehurst P; Wilson EC
Health Technol Assess; 2021 Feb; 25(15):1-190. PubMed ID: 33656977
[TBL] [Abstract][Full Text] [Related]
13. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of quantitative fetal fibronectin in predicting spontaneous preterm birth in symptomatic women: A retrospective cohort study.
Nguyen AD; Liu CZ; Lehner C; Amoako AA; Sekar R
Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):656-661. PubMed ID: 30724331
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor.
Nikolova T; Bayev O; Nikolova N; Di Renzo GC
J Perinat Med; 2015 Jul; 43(4):395-402. PubMed ID: 25562603
[TBL] [Abstract][Full Text] [Related]
16. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.
van Baaren GJ; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HCJ; Spaanderman MEA; Bloemenkamp KWM; Haak MC; Bax CJ; Cornette JMJ; Duvekot JJ; Nij Bijvanck BWA; van Eyck J; Franssen MTM; Sollie KM; Vandenbussche FPHA; Woiski M; Bolte AC; van der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ
Ultrasound Obstet Gynecol; 2018 May; 51(5):596-603. PubMed ID: 28370518
[TBL] [Abstract][Full Text] [Related]
18. Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis.
Stock SJ; Wotherspoon LM; Boyd KA; Morris RK; Dorling J; Jackson L; Chandiramani M; David AL; Khalil A; Shennan A; Hodgetts Morton V; Lavender T; Khan K; Harper-Clarke S; Mol BW; Riley RD; Norrie J; Norman JE
BMJ Open; 2018 Apr; 8(4):e020796. PubMed ID: 29627817
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
